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September 2011912 Abstractsthe United States. Patients were excluded if they underwent an EVAR in the
context of premarketing or postmarketing studies in which M2S served as a
core imaging laboratory. Preoperative aorta iliac anatomic characteristics
were reviewed for each patient. The specific endovascular device implanted
was not available from this database. Morphologic measurements were
therefore compared with the most liberal and most conservative published
anatomic guidelines stated in manufacturer’s IFUs. Primary outcome was
post-EVAR aneurysm sac enlargement5 mm. There were 10,228 patients
included in the database and used for the study. Of these, 59% had a
maximum abdominal aortic aneurysm diameter below the 55-mm threshold
at which intervention is recommended over surveillance. Forty-two percent
of patients had anatomy that met the most conservative definition of IFUs
and 69% met the most liberal definition of device IFUs. The 5-year post-
EVAR rate of AAA sac enlargement was 41%. Independent predictors of
AAA sac enlargement included age 80 years, endoleak, aortic neck diam-
eter 28 mm, aortic neck angle 60°, and common iliac artery diameter
20 mm.
Comment: Some physicians placing EVAR devices may be acting in
what some could consider an irresponsible fashion. In this study, most
EVAR devices were placed in abdominal aortic aneurysms that were below
the threshold for intervention justified by randomized trials. Even with the
most liberal definition of IFUs almost one-third of devices were placed
outside manufacturer’s recommendations, and in this database, 40% of
aortas treated with EVAR had aneurysm sac enlargement at 5 years. The data
are disturbing and raise significant questions about aneurysm treatment in
the United States and about long-term risk of aneurysm rupture in patients
treated with EVAR in the United States. Physicians placing EVAR devices
need to do better job of policing themselves. If not, one can be sure someone
else will! One can only speculate that it won’t take long for the malpractice
attorneys to stumble on to this.
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Conclusion: A recent myocardial infarction (MI) is a significant risk
factor for postoperative MI and mortality. When possible, delaying the
operation for 8 weeks after MI and medical optimization should be consid-
ered before elective surgery.
Summary: No large contemporary studies have assessed the risk of
surgery for patients with a history of recent MI. Advances in reducing
operative complications may reduce postoperative morbidity and mortality
in patients with cardiac risk factors. Such advances, in fact, may also reduce
t
Mhe risk of a subsequent MI in a patient with a recent MI undergoing elective
urgery. The authors examined five common noncardiac operations (hip
urgery, colectomy, cholecystectomy, abdominal aortic aneurysm repair,
nd amputation) to determine whether a recent MI remains a risk factor for
oor postoperative outcomes and whether that risk can be lessened by time
lapsed from the MI. The authors used the California Patient Discharge
atabase to retrospectively analyze patients undergoing the five index pro-
edures from 1999 to 2004 (n 563,842). They evaluated the incidence of
ostoperative 30-day MI, 30-day mortality, and 1-year mortality and com-
ared these values for patients with or without a recent MI. Relative risk
RR) with 95% confidence intervals were estimated using boot strapping
ith 1000 repetitions.
The postoperative MI rate for the recent MI cohort decreased substan-
ially as the length of time between MI and the operation increased: 0-30
ays, 32.8%; 31-60 days, 18.7%; 61-90 days, 8.4%; and 91-180 days, 5.9%.
he 30-day mortality also decreased as length from recent MI increased:
-30 days, 14.2%; 31-60 days, 11.5%; 61-90 days, 10.5%; and 91-180 days,
.9%. An MI occurring 30 days of an operation was associated with a
igher risk of postoperative MI (RR range, 9.98-44.29 for the 5 proce-
ures), 30-day mortality (RR range, 1.83-3.84), and 1-year mortality (RR
ange, 1.56-3.14). The 30-day mortality rate was 10.3% in patients under-
oing abdominal aortic aneurysm repair30 days of a recent MI and 17.2%
or patients undergoing amputation 30 days of a recent MI (14.3% for
elow knee amputation and 23.0% for above knee amputation). The 1-year
ortality for patients undergoing below knee amputation30 days of a MI
as 47.0% and 1-year mortality for patients undergoing above knee ampu-
ation 30 days of a MI was 67.5%. Despite these numbers, the risk of
ostoperative MI for patients with MI 30 days of operation was actually
ower in patients undergoing abdominal aortic aneurysm repair or amputa-
ion compared with those undergoing a nonvascular procedure. Patients
ndergoing abdominal aortic aneurysm repair or amputation also appeared
o have a lower rate of 30-day and 1-year mortality compared with patients
ndergoing the nonvascular procedures.
Comment: A recent MI remains a significant risk factor for postoper-
tive MI and death. Surprisingly, the increased risk of postoperative MI after
recent MI appears greater for nonvascular operations. It would be useful in
uture studies to examine clinical factors such as -blocker therapy, blood
ressure control, and statin use and their effects on the postoperative MI rate
n patients undergoing elective surgery after a recent MI. It is best to wait as
ong as possible after a MI before proceeding with elective surgery. Most of
he benefit, however, appears to be achieved after waiting 2 months after a
I.
